# The TRUST Trial - CardioVascular Imaging ECHO

> **NCT02832960** · PHASE4 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 185 (actual)

## Conditions studied

- Thyroid Dysfunction
- Atherosclerosis
- Heart Failure

## Interventions

- **DRUG:** Levothyroxine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02832960
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2017-02-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02832960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02832960, "The TRUST Trial - CardioVascular Imaging ECHO". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02832960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*